The Ensign Group, Inc. (ENSG) is a publicly traded Healthcare sector company. As of September 18, 2026, ENSG trades at $175.77 with a market cap of $10.37B and a P/E ratio of 26.59. ENSG moved +0.49% today. Year to date, ENSG is +0.57%; over the trailing twelve months it is +5.41%. Its 52-week range spans $118.73 to $218.00. Analyst consensus is strong buy with an average price target of $217.50. Rallies surfaces ENSG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for ENSG, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $175.77 |
| Market Cap | $10.37B |
| P/E Ratio | 26.59 |
| EPS | $6.57 |
| Dividend Yield | 0.07% |
| 52-Week High | $218.00 |
| 52-Week Low | $118.73 |
| Volume | 354 |
| Avg Volume | 0 |
| Revenue (TTM) | $5.49B |
| Net Income | $379.04M |
| Gross Margin | 20.73% |
4 analysts cover ENSG: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $217.50.